ABOUT ENZYMATICA RESEARCH DEVELOPMENT PRODUCTS INVESTOR NEWS Our business concept is to offer effective help against some of our most common public diseases where viruses or bacteria play a crucial role. In this way, we contribute to improved health and increased well-being, which in turn can have positive health economic effects. Press releases 2016-08-30 Enzymatica AB: The board of Enzymatica decides on targeted new… 2016-07-18 Enzymatica AB: Good volume development for ColdZyme® To the archive Financial reports 2016-07-18 Enzymatica Interim Report January-June 2016 2016-04-20 Enzymatica's annual report 2015 To the archive Other news 2016-04-26 Customer Studies: ColdZyme users act early and actively in colds 2016-04-20 Information about Enzymatica's new issue To the archive ABOUT ENZYMATICA Business concept and goals Sustainability work Work with us History Contact Us RESEARCH DEVELOPMENT Product development Clinical studies Publications Scientific advisors PRODUCTS ColdZyme® Mouth Spray for colds Calvate ™ - veterinary products Zymetech products INVESTOR Stock information Financial reports Corporate governance Company description First North Presentations Company analyzes Calendar IR contact New issue April 2016 NEWS Press releases Other news Subscribe Image Bank PLUG Ideon Science Park SE-223 70 Lund, Sweden Visit: Scheelevägen 19 Tel: +46 (0) 46-286 31 00 E-mail: info@enzymatica.se TWITTER Fetching Enzymatica tweets ... © 2014-2015 Enzymatica AB